Acadia Pharmaceuticals Inc. is dedicated to improving the lives of patients with neuro-psychiatric and rare diseases. The company has developed FDA-approved drugs for Parkinson’s disease psychosis and Rett syndrome, and is currently focused on treating Prader-Willi syndrome, Alzheimer’s disease psychosis, and other neurological conditions through clinical-stage development efforts.
Acadia Pharmaceuticals is seeking a Director of Field Force Effectiveness for its Neuro-Psych franchise. This role will lead the strategy, design, and execution of initiatives to drive performance and impact of field-based teams. The Director will partner with various leadership teams to ensure field teams are optimally deployed, effectively targeted, and motivated, with a focus on patient outcomes and business growth. The position requires expertise in biopharmaceutical commercialization and a collaborative, analytical approach.
Acadia Pharmaceuticals Inc. is dedicated to improving the lives of patients with neuro-psychiatric and rare diseases. The company has developed FDA-approved drugs for Parkinson’s disease psychosis and Rett syndrome, and is currently focused on treating Prader-Willi syndrome, Alzheimer’s disease psychosis, and other neurological conditions through clinical-stage development efforts.
Axsome Therapeutics